Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507234 · ClinicalTrials.gov registry record · Phase 3
Study in Subjects Greater Than 40 Years of Age With COPD
A Phase 3 study, sponsored by Dey.
- Completed
- Registry status
- Phase 3
- Development phase
- 128
- Enrollment target
NCT00507234 is a Phase 3 study that has completed, run by Dey. The registered enrollment target is 128 participants.
The verdict
NCT00507234, a Phase 3 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 128 participants
- Enrollment target
Study Summary
This is a multicenter, Phase IIIb, randomized, double-blind, active-controlled, parallel-group, comparative study. The objectives of this study are: 1. To compare the efficacy of tiotropium 18 mcg once daily plus Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg twice daily to tiotropium 18 mcg once daily. 2. To obtain safety data on the use of tiotropium 18 mcg once daily plus FFIS 20 mcg twice daily compared to tiotropium 18 mcg once daily.
Interventions
- DRUG formoterol fumarate inhalation solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507234
The ClinicalTrials.gov registry entry for NCT00507234 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which formoterol fumarate inhalation solution is the first listed.
NCT00507234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507234 about?
NCT00507234 is a clinical study titled "Study in Subjects Greater Than 40 Years of Age With COPD". This is a multicenter, Phase IIIb, randomized, double-blind, active-controlled, parallel-group, comparative study. The objectives of this study are: 1. To compare the efficacy of tiotropium 18 mcg once daily plus Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg twice daily to tiotropium 18 mc...
What is the current status of trial NCT00507234?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 128 participants. The study started on 2007-03. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00507234?
The interventions under investigation include: formoterol fumarate inhalation solution (DRUG).
Who is sponsoring clinical trial NCT00507234?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.